Viewing Study NCT02105766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-03-16 @ 1:24 AM
Study NCT ID: NCT02105766
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2014-04-01
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
None Thalassemia View
None Stem Cell Transplantation View
None Graft vs Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle Cell Disease View
None Allogeneic Hematopoietic Stem Cell Transplant View
None Pentostatin (Nipent) View
None Cyclophosphamide View
None Alemtuzumab (Campath) View